JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
TARS - Tarsus Pharmaceuticals, Inc.
USD | NASDAQ | Healthcare
Summary
Summary TARS Stock
Financials
Financials TARS Stock
Loading...
Loading...
Income Statement
Income Statement TARS Stock
Balance Sheet
Balance Sheet TARS Stock
Cash Flow Statement
Cash Flow Statement TARS Stock
Loading...
Loading...
TARS Financials - Tarsus Pharmaceuticals Income & Cash Flow | Ledgeburg
Home
Stocks
Tarsus Pharmaceuticals, Inc. (TARS)
Financials
Financials of TARS
Loading...
Loading...
Loading...
Loading...
Revenue
$451.36M
Operating Income
$-70.969M
Net Income
$-66.418M
Share Count (Basic)
41.784014M
Operating Cash Flow
$-12.451M
Free Cash Flow
$-22.31M
Cash And Short-Term Equivalents
$417.267M
Total Debt
$72.438M
Annual
Quarterly
Revenue $USD
0
100M
200M
300M
400M
500M
FY2021
FY2022
FY2023
FY2024
Revenue $USD
0
50M
100M
150M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-100M
-50M
FY2021
FY2022
Annual
Quarterly
Margins
Gross
Operating
Net
-800%
-600%
-400%
-200%
0%
FY2025
FY2023
FY2024
FY2025
Net Income $USD
-25M
-20M
-15M
-10M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
0%
50%
100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26